Literature DB >> 20851812

Antibiotic stewardship programmes--what's missing?

Esmita Charani1, Jonathan Cooke, Alison Holmes.   

Abstract

Inappropriate antibiotic use and antibiotic resistance are now major global issues. Antimicrobial stewardship programmes are increasingly being used to optimize antibiotic prescribing in acute care. The central tenet of these programmes tends to be policy and guidelines aimed at prescribers. However, rules and guidelines alone may not be sufficient to bring about effective and sustainable optimization of practice. Best practice needs to be positively reinforced by an environment that facilitates and supports optimal prescribing choices, i.e. a 'choice architecture' that makes prudent antibiotic prescribing the path of least resistance. To make prudent antibiotic management an integral part of the behaviour of all healthcare professionals and to bring about quality improvement it is necessary to adopt a whole-system approach. To do this it is necessary first to understand the factors that influence antibiotic management and prescribing.

Mesh:

Substances:

Year:  2010        PMID: 20851812     DOI: 10.1093/jac/dkq357

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  41 in total

Review 1.  Antimicrobial Stewardship: A Call to Action for Surgeons.

Authors:  Massimo Sartelli; Therese M Duane; Fausto Catena; Jeffrey M Tessier; Federico Coccolini; Lillian S Kao; Belinda De Simone; Francesco M Labricciosa; Addison K May; Luca Ansaloni; John E Mazuski
Journal:  Surg Infect (Larchmt)       Date:  2016-11-09       Impact factor: 2.150

2.  The determinants of antimicrobial prescribing among hospital doctors in England: a framework to inform tailored stewardship interventions.

Authors:  Hazel M Parker; Karen Mattick
Journal:  Br J Clin Pharmacol       Date:  2016-05-18       Impact factor: 4.335

3.  Endless Resistance. Endless Antibiotics?

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Medchemcomm       Date:  2015-11-03       Impact factor: 3.597

4.  Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy.

Authors:  Daniele Roberto Giacobbe; Valerio Del Bono; Malgorzata Mikulska; Giulia Gustinetti; Anna Marchese; Federica Mina; Alessio Signori; Andrea Orsi; Fulvio Rudello; Cristiano Alicino; Beatrice Bonalumi; Alessandra Morando; Giancarlo Icardi; Sabrina Beltramini; Claudio Viscoli
Journal:  Infection       Date:  2017-08-30       Impact factor: 3.553

5.  A microbiologist consultant should attend daily ICU rounds.

Authors:  J Schouten; G De Angelis; J J De Waele
Journal:  Intensive Care Med       Date:  2019-11-14       Impact factor: 17.440

6.  The effect of a whole-system approach in an antimicrobial stewardship programme at the Singapore General Hospital.

Authors:  J Teo; A L H Kwa; J Loh; M P Chlebicki; W Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-10       Impact factor: 3.267

7.  Taking an Antibiotic Time-out: Utilization and Usability of a Self-Stewardship Time-out Program for Renewal of Vancomycin and Piperacillin-Tazobactam.

Authors:  Christopher J Graber; Makoto M Jones; Peter A Glassman; Charlene Weir; Jorie Butler; Kevin Nechodom; Chad L Kay; Amy E Furman; Thuong T Tran; Christopher Foltz; Lori A Pollack; Matthew H Samore; Matthew Bidwell Goetz
Journal:  Hosp Pharm       Date:  2015-11-24

Review 8.  The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance.

Authors:  Melinda M Pettigrew; J Kristie Johnson; Anthony D Harris
Journal:  Ann Epidemiol       Date:  2016-03-08       Impact factor: 3.797

9.  The Human Microbiome and Public Health: Social and Ethical Considerations.

Authors:  Kieran C O'Doherty; Alice Virani; Elizabeth S Wilcox
Journal:  Am J Public Health       Date:  2016-01-21       Impact factor: 9.308

Review 10.  Bloodstream infections in internal medicine.

Authors:  Valerio Del Bono; Daniele Roberto Giacobbe
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.